首页|垂体神经内分泌肿瘤侵袭性相关生物标志物的研究进展

垂体神经内分泌肿瘤侵袭性相关生物标志物的研究进展

扫码查看
可靠的生物标志物对侵袭性垂体神经内分泌肿瘤(PitNETs)的早期诊断、有效治疗和预后评估非常重要。随着研究的积累,临床对于PitNETs的发生和发展过程已经有了更深入的了解,许多能够参与Pit-NETs 侵袭性生长的生物分子已被报道。但由于PitNETs各亚型间异质性较大,涉及多维度高复杂性的调控网络,目前能够应用于临床诊疗的生物标志物仍十分稀少。该文对PitNETs侵袭性相关的生物标志物展开综述,进一步阐述PitNETs侵袭性背后的机制,为寻找PitNETs诊断、治疗及预后评估的靶点提供了思路。
Research progress on biomarkers related to aggressiveness in pituitary neuroendocrine tumors
Reliable biomarkers are very important for early diagnosis,effective treatment and prognos-tic assessment of aggressive pituitary neuroendocrine tumors(PitNETs).With the accumulation of resear-ches,the occurrence and development of PitNETs have been better understood,and many biomolecules that can participate in the aggressive growth of PitNETs have been reported.However,due to the large heterogene-ity among the subtypes of PitNETs and the involvement of multi-dimensional and highly complex regulatory networks,there are still very few biomarkers that can be applied to clinical diagnosis and treatment.This arti-cle reviews the biomarkers related to the invasiveness of PitNETs,further elaborates the mechanism behind the invasiveness of PitNETs,and provides the ideas for finding the target spots for the diagnosis,treatment and prognosis evaluation of PitNETs.

pituitary neuroendocrine tumorsinvasivebiomarkerssubtypereview

张港、邵川、吴南

展开 >

重庆医科大学,重庆 400016

重庆市人民医院神经外科,重庆 401147

垂体神经内分泌肿瘤 侵袭性 生物标志物 亚型 综述

重庆市科学技术局基金项目

CSTB2022NSCQ-MSX0548

2024

重庆医学
重庆市卫生信息中心,重庆市医学会

重庆医学

CSTPCD
影响因子:1.797
ISSN:1671-8348
年,卷(期):2024.53(19)
  • 2